05 Nov Perfusion Fermentation Sets A Path To Democratize Biomanufacturing.

I had the chance to attend INTERPHEX Global at the Javits Center back in April and in my quest to find new fluidic applications, I discovered Sunflower Therapeutics, in which solutions include: The first microbial perfusion fermentation system designed and built for continuous protein production, allowing you to make more protein with less space, effort, and cost.

I found this recent paper in Trends in Biotechnology entitled “Perfusion fermentation sets a path to democratize biomanufacturing” written by Kerry Love Stacy Martin Devin Grace Morrison Laura Crowell of Sunflower Therapeutics to be quite interesting.
As the bioeconomy grows, protein production is becoming essential for industries like healthcare, food, and electronics. Sunflower Therapeutics is leading the way with innovative biomanufacturing solutions, introducing the Daisy Petal™ perfusion bioreactor system.

• Innovative, Cost-Effective Solutions: The fully automated, small-footprint system enables continuous protein production from microorganisms, offering lower costs, a smaller manufacturing footprint, and high product quality.
• Accessible to All: With intuitive software (HelianthOS™) and easily distributed systems, Sunflower is democratizing biomanufacturing, allowing innovators from diverse backgrounds to easily engage in protein production.
• Scalable and Sustainable: The Daisy Petal™ system supports seamless scaling from research to commercial production, making biotechnology accessible globally, especially in regions with limited resources.
Please refer to this link.